AllSight
Companies · BAX · Surgical & Medical Instruments & Apparatus

BAXTER INTERNATIONAL INC (BAX)

BAXTER INTERNATIONAL INC (BAX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

BAXTER INTERNATIONAL INC (BAX) stock — financials & valuation

Key numbers for BAXTER INTERNATIONAL INC (BAX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 35/100 — a percentile rank of BAXTER INTERNATIONAL INC’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$12.2B
P / S1.1×
EV / EBITDA18.6×
Gross margin30.1%
Operating margin-3.4%
Net margin-8.8%
Return on equity-16.2%
ROIC-5.8%
Revenue growth5.4%
Debt / equity1.5×
Dividend yield1.5%

Is BAXTER INTERNATIONAL INC overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from BAXTER INTERNATIONAL INC’s own financial statements and shown as context, never as advice.

Aug 19, 2026Incoming CFO
Baxter names John Rogers as CFO, but appointment remains conditional
Aug 18, 2026Credit agreement amended
Baxter amends credit agreement, tightening leverage later but adding acquisition flexibility
Aug 4, 2026
Interim CFO and chief accounting officer exits September 15; succession now the issue.
Aug 4, 2026$500M debt tender offer
Baxter launches a $500 million debt tender, extending deleveraging
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact